Physician profile
David C Pires
NPI 1821135799
$17,836.05
in general payments reported to CMS, 2019-2025
24 companies · $1,185 in 2025
The $1,185 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,789 · 2020: $4,109 · 2021: $2,324 · 2022: $2,422 · 2023: $2,796 · 2024: $2,212 · 2025: $1,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,192.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,933.63 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Nevro Corp. | $3,820.40 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,022.12 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Medtronic USA, INC. | $850.01 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $695.47 | 2022 | |
| Foundation Fusion Solutions, LLC | $609.55 | 2022-2025 | |
| Vertiflex, INC. | $592.96 | 2019 | |
| Nalu Medical, INC. | $535.16 | 2024-2025 | Nalu Neurostimulation System |
| Bioventus LLC | $347.01 | 2019-2023 | Supartz Fx Sodium Hyaluronate |
| Medtronic, INC. | $343.80 | 2021-2023 | Intellis Adaptivestim, Synchromedii |
| Painteq LLC | $329.68 | 2022-2024 | Painteq |
| Sanara Medtech INC. | $171.93 | 2021 | |
| Flowonix Medical Incorporated | $97.14 | 2019 | |
| Abbvie INC. | $83.75 | 2021-2024 | |
| Allergan, INC. | $73.90 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $71.35 | 2022-2023 | |
| Relievant Medsystems, INC. | $62.56 | 2023 | Intracept |
| Globus Medical, INC. | $47.39 | 2025 | Senza, Vyrsa V1 |
| Biodelivery Sciences International, INC. | $35.17 | 2019-2020 | |
| Pfizer INC. | $29.61 | 2019 | |
| Depuy Synthes Sales INC. | $25.32 | 2022 | |
| Scilex Pharmaceuticals INC. | $23.76 | 2019 | |
| Vertos Medical, INC. | $18.75 | 2022 | |
| Spr Therapeutics, INC | $15.63 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pires listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.